Effect of prolonged expressive writing on health outcomes in breast cancer patients receiving chemotherapy: a multicenter randomized controlled trial.

Wu Y, Liu L, Zheng W, Zheng C, Xu M, Chen X, Li W, Xie L, Zhang P, Zhu X, Zhan C, Zhou C

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · February 1, 2021

Randomized Controlled Trial🇨🇳China

A total of 112 breast cancer patients undergoing chemotherapy were randomly allocated to the expressive writing group or the prolonged expressive writing group. All participants were required to write about their stressor-related upsetting or traumatic feelings about breast cancer. There was no significant difference in the patients' quality of life, or physical and psychological wellbeing between the expressive writing group and the prolonged expressive writing group at any time point (all p > .05). Our findings suggest that the writing dosage does not moderate the effects of expressive writing on breast cancer patients undergoing chemotherapy.

PMID: 32601853 · DOI: 10.1007/s00520-020-05590-y

View original study ↗

Effect of prolonged expressive writing on health outcomes in breast cancer patients receiving chemotherapy: a multicenter randomized controlled trial.

Evaluation of expressive writing for postpartum health: a randomised controlled trial.

Expressive writing intervention and self-reported physical health out-comes - Results from a nationwide randomized controlled trial with breast cancer patients.

The effect of expressive writing intervention on psychological and physical health outcomes in cancer patients--a systematic review and meta-analysis.

Randomized controlled trial of expressive writing for psychological and physical health: the moderating role of emotional expressivity.